Lee Sung Gyu
Division of Hepatopancreatobiliary Surgery and Liver Transplantation, Asan Medical Center, Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea.
Korean J Gastroenterol. 2005 Aug;46(2):75-83.
Orthotopic liver transplantation (OLT) is now considered as a standard procedure for patients with end-stage liver disease. The number of patients listed for OLT using the brain-dead donor continues to outpace the number of OLT performed since early 1990s because the improved results of OLT had made it as a therapeutic means for irreversible liver disease. This scarcity of organs from the deceased donors has resulted in the increased use of the living donor liver grafts. Although the shortage of the brain-dead donor organs is a world-wide problem, the situation is especially serious in our country, where the deceased donor organ donation remains below 2 per million population per year. Now, Korea has the greatest need for living donor liver transplantation although it is more complex and demanding procedure than the deceased donor (whole organ) liver transplantation. Refinements of the technique and good results have rapidly established the position of the living donor liver transplantation in our country's transplant medicine. 2,345 OLTs (1,860 from the living donor and 485 from the deceased donor) were performed in 24 institutes from March 1988 to December 2004, although 5 institutes had performed more than 10 OLTs per year. Definitely, living donors represent a large pool of organs, but there might be a significant cost, mainly donor risk, to draw from this pool. To alleviate some disadvantages of the living donor liver transplantation and to provide organ to the patients who cannot find out the potential living donor from family members, recognition of necessity and nation-wide cooperative participation of organ donation after the brain-death should be propagated and encouraged in our country.
原位肝移植(OLT)目前被视为终末期肝病患者的标准治疗手段。自20世纪90年代初以来,使用脑死亡供体进行OLT登记的患者数量持续超过实际进行OLT的数量,因为OLT效果的改善使其成为不可逆肝病的一种治疗方法。已故供体器官的稀缺导致活体供肝移植的使用增加。尽管脑死亡供体器官短缺是一个全球性问题,但在我国情况尤为严重,我国每年每百万人口中已故供体器官捐献率仍低于2例。现在,韩国对活体供肝移植的需求最大,尽管它比已故供体(全器官)肝移植更为复杂且要求更高。技术的改进和良好的效果迅速确立了活体供肝移植在我国移植医学中的地位。1988年3月至2004年12月期间,24家机构共进行了2345例OLT(1860例来自活体供体,485例来自已故供体),其中5家机构每年进行的OLT超过10例。当然,活体供体代表了大量的器官来源,但从这个来源获取器官可能会有巨大成本,主要是供体风险。为了减轻活体供肝移植的一些弊端,并为那些无法从家庭成员中找到潜在活体供体的患者提供器官,我国应宣传并鼓励认识到脑死亡后器官捐献的必要性以及全国范围内的合作参与。